Review
Aug 2026
Injectable antiplatelet therapies in acute coronary syndromes: Current status and Emerging Therapies. A position paper of the Task Force of Antithrombotic therapy of the ACVC.
There is emerging data that these agents achieve rapid platelet inhibition, improve coronary flow and clinical outcomes particular in high risk ACS patients, such as those with cardiogenic shock.
U. Zeymer, S. Koolaji, D. Araiza-Garaygordobil et al.
· European heart journal. Acut... · 0 citations